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• Globally, about 10% of pregnant women 
experience increased blood pressure, and 
between 2-8% of pregnant woman experience 
pre-eclampsia and eclampsia-related 
complications.
• Among pre-eclampsia patients, 10% develop 
eclampsia, which contributes to between 10% 
and 20% of maternal deaths globally each year.
• Prescribing low-dose aspirin and calcium to 
at-risk women can prevent pre-eclampsia and 
eclampsia (PE/E).
• Pre-eclampsia and eclampsia can be managed 
by administering anti-hypertensive drugs and 
magnesium sulphate (MgSO4).
• MgSO4 is the safest and most effective treatment 
for severe PE/E, and is one of 13 UN Life-Saving 
Commodities for Women and Children. 
• PE/E and other hypertensive disorders in 
pregnancy increase the risk of pre-term births, 
which can lead to low birth weight, anemia, and 
stunting.
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OPERATIONALIZING NATIONAL PROTOCOL 
FOR PREVENTING AND MANAGING PE/E IN 
COMMUNITY FACILITIES IN BANGLADESH
Background
In Bangladesh, between 5,000 and 6,000 women die 
every year from pregnancy-related complications. There 
is no study that specifically measures the incidence and 
prevalence of pre-eclampsia and eclampsia (PE/E), but 
the 2010 Bangladesh Maternal Mortality Survey (BMMS 
2010) suggests post-partum hemorrhage (31%), PE/E 
(20%), and prolonged and obstructed labor (7%) are 
the three main causes of maternal mortality. 
The World Health Organization (WHO) recommends 
magnesium sulphate (MgSO4) as the most effective, 
safe, and low-cost anticonvulsant treatment for PE/E. 
In Bangladesh, the drug is registered and has been in 
use at secondary and tertiary facilities for 30 years, but 
it is not available in primary facilities. 
Considering the maternal deaths associated with PE/E, 
the Ministry of Health and Family Welfare, with technical 
assistance from the Obstetrical and Gynecological 
Society of Bangladesh, developed a national protocol 
allowing community providers to give an MgSO4 loading 
dose. 
At the approval of the National Technical Committee 
of Directorate General of Family Planning, this study 
operationalized and assessed the ability of community 
providers to detect and treat PE/E, and administer a 
loading dose of MgSO4 before referral to higher-level 
facilities. This brief details those findings.  
Methods
The study took place between July 2013 and July 2014 
in the Sarail and Kasba upazilas of Brahmanbaria 
District. Fieldworkers conducted awareness-raising 
activities, identified high-risk pregnant women, and 
referred them to the Union Health & Family Welfare 
Centers (UH&FWCs). The intervention involved training 
community health providers to screen for, and detect, 
PE/E, and to administer an MgSO4 loading dose to 
prevent and control convulsions/seizures. Trainings 
included orienting fieldworkers to educate pregnant 
women about PE/E, identify high-risk pregnant women and 
refer them to community facilities, and establish linkages 
between community and referral facilities. 
Researchers trained district and upazila program managers 
and service providers on their roles in managing PE/E 
cases, provided them with educational materials, and made 
sure facilities had the supplies and equipment necessary 
to detect and treat PE/E. After the trainings, researchers 
assessed: 
•  The capacity of providers, including family welfare 
visitors (FWVs), sub-assistant community medical 
officers (SACMOs), nurses, community skilled birth 
attendant (CSBAs) and community health care providers 
(CHCPs) to screen and detect PE/E;
•  Providers’ ability to administer a loading dose of MgSO4, 
and refer patients to secondary facilities;
•  Efficacy of referral mechanisms between primary and 
secondary facilities; and
• The overall cost of interventions and the cost of potential 
scale up. 
Results
Knowledge on danger signs
Before the trainings and after the intervention, researchers 
interviewed community providers to understand their 
knowledge of life-threatening complications, signs, and 
symptoms of PE/E observed during the antenatal, postnatal, 
and delivery periods. The baseline knowledge on life 
threatening complications was already high, but it improved 
marginally due to the intervention. 
For example, 89% of respondents during the baseline 
survey mentioned that eclampsia/seizure is a complication 
during the antenatal period, but that increased to 94% at 
the endline survey (p>.10). Similarly, 77% of respondents 
before the trainings mentioned severe headaches as a 
complication during the antenatal period. This increased to 
92% at the endline survey.   
Table 1 shows the increase in providers’ knowledge on 
danger signs during pregnancy. 
TABLE 1. COMMUNITY SERVICE 
PROVIDERS’ KNOWLEDGE ON DANGER 
SIGNS DURING PREGNANCY (%)
Findings suggest there was a significant improvement in 
knowledge about PE/E at the post-intervention period 
compared to pre-intervention period. Knowledge of signs 
and symptoms of PE/E also improved after the intervention. 
Knowing that high blood pressure is a sign of PE improved 
significantly from 60% at the baseline to 91% at the post-
intervention survey (p<.05). 
Similarly, knowledge on presence of protein in the urine as a 
sign of severe PE in addition to high blood pressure increased 
from 26% at the pre-intervention survey to 57% (p<.05). 
Findings suggest there was a significant improvement in 
the knowledge of PE/E at the post-intervention period 
compared to pre-intervention period. 
Knowing high blood pressure is a sign of PE increased 
significantly from 60% at the baseline to 91% at the post-
intervention survey (p<.05). Similarly, knowledge on 
presence of protein in the urine as a sign of severe PE, in 
addition to high blood pressure, increased from 26% at the 
pre-intervention survey to 57% (p<.05). 
See Table 2 for details on community providers’ knowledge 
of pre-eclampsia, severe pre-eclampsia, and eclampsia. 
Pre-intervention Post-intervention
Knowledge of 
danger signs* 
(n=105) (n=105)
Seizures/con-
vulsions
88.6 94.3
Severe 
headache and 
blurred vision
77.1 92.4
Vaginal bleed-
ing
91.4 89.5
High fever 80.0 84.8
Others 10.5 1.0
*Multiple Responses 
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TABLE 2. COMMUNITY PROVIDERS’ 
KNOWLEDGE OF SIGNS AND SYMPTOMS OF 
PE/SPE/E
Prior to the intervention, there was no documented PE/E 
patient in the selected intervention upazilas, but during the 
intervention period 33 PE/E patients sought services. District-
level findings suggest the majority of PE/E patients directly 
seek services from district hospitals. 
Explanations for this vary, but community facility providers 
believe the main reasons for seeking services from district 
hospitals were easy transportation, awareness of available 
specialist care, and a lack of confidence in community facilities.
Program managers said people go directly to district hospitals 
because of a lack of providers at community facilities and the 
perception that service providers are incapable of managing 
PE/E patients and emergency other conditions.
More than 40% of PE/E patients received treatment at the Sadar 
Upazila UH&FWCs, which are close to nearby referral facilities. 
Interviews show that these providers are more confident in 
their ability to treat patients because it is relatively easy to get 
assistance from referral facility providers when needed. 
Although, SACMOs, nurses, CHCPs, and CSBAs received 
training and were included in the service provision, only 
FWVs at UH&FWCs treated patients.  
The district hospital documented outcomes of referred 
PE/E patients. Among those who received MgSO4 
injection at a community health facility, there were no 
maternal deaths but one newborn death. No serious 
adverse effects due to loading dose of MgSO4 were 
reported among the study population.
Referral linkages 
At district hospitals, PE/E patients can receive all 
services needed, including caesarian sections, which 
makes district hospitals the best place to refer PE/E 
patients. Results indicate that effective referral linkages 
between community facilities and secondary facilities 
are possible. However, primary facility providers did not 
correctly use referral slips developed by the Council. 
Also, in some cases providers consulted referral facility 
providers before treating an eclamptic patient. 
Cost of intervention and scaling up
This analysis assumed FWVs/SACMOs are the main 
service providers for administering loading dose of 
MgSO4 at community facilities.  The unit cost for scaling 
up the intervention per upazila/sub-district is US $7,948, 
and the recurrent cost for continuing the program every 
year is US $2,052. 
If refresher trainings are planned,  there is an additional 
cost of US $4,046 per upazila per training. Other service 
providers like CSBAs, CHCPs, nurses, and FWVs would 
also need training to detect and refer clients to the 
UH&FWCs for further management.
Challenges
• People living in rural areas are not fully aware of the 
signs and symptoms of PE/E. Some  considered 
danger signs to be normal occurrences during 
pregnancy. Sensitization and education by 
fieldworkers would be difficult, as most of them do 
not visit homes and are already overburdened with 
their assigned roles.
• Regular measurement and documentation of blood 
pressure and protein in urine during antenatal and 
postnatal care visits and during delivery by primary 
facility providers is vital but challenging due to limited 
resources.  
• In some instances, patients and their attendants 
refused to receive or give a MgSO4 injection at 
community facilities due to lack of confidence in 
community  facility providers. Sometimes it was very 
difficult to convince the attendants about the nature 
of emergency management and referral needed for 
patients.
Pre-interven-
tion
Post-intervention
Signs and symptoms* (n=105) (n=105)
Signs of pre-eclampsia*
High blood pressure 60.0 91.4
Excess protein in urine 25.7 57.1
Headache 0.0 27.6
Blurred vision 0.0 21.9
Edema 0.0 12.4
Signs of severe pre-eclampsia
Pregnancy-induced high blood 
pressure
63.8 94.3
Protein in urine 28.6 84.8
Severe headache 60.0 67.6
Blurred vision/light sensitivity/
seeing spots
42.9 61.0
Upper abdominal pain (usually 
under ribs on right side)
8.6 51.4
Edema (swelling), particularly in 
face and hands 
57.1 46.7
Signs of eclampsia 
Pregnancy-induced high blood 
pressure, plus:
59.0 67.3
Seizures/convulsions 97.1 98.2
Protein in urine 24.8 54.8
*Multiple responses 
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•  The number of pregnant women seeking antenatal 
care, delivery assistance, and postnatal care at facilities 
did not increase due to new intervention, which is 
problematic if pregnancy-related complications are to 
be detected. 
• Motivating service providers to write complete 
information about a patient warrants a frequent, strong 
monitoring and supervision system. 
Recommendations
These study results indicate that with national protocol, 
training, and mentorship health providers at diverse levels 
of the health care system can detect PE/E, provide the 
loading dose of MgSO4, and refer patients to higher level 
facilities for further management. Despite this, further 
improvements are needed, and are listed below.
• FWVs and SACMOs should utilize national protocols for 
PE/E management at community facilities, with close 
monitoring of cases; 
• The MgSO4 injection loading dose should be available 
in one or two vials, rather than four vials, which is 
currently available. This requires advocacy targeted at 
manufacturers; 
• All essential instruments and equipment must be 
available and functioning at the community facilities; 
• Fieldworkers should identify PE/E patients to refer to 
community health facilities; 
• Each referral facility should have a focal person familiar 
with the referral system, and all service providers should 
recognize this person as a resource for PE/E cases;  
• Trainings should include broader issues of maternal 
health like antenatal care, postnatal care, delivery, and 
newborns, in addition to PE/E. These areas should be 
incorporated into refresher trainings that take place six 
months after the intervention starts; and  
• Mass promotion campaigns on PE/E and treatment 
services in communities would encourage pregnant 
women to seek services at facilities. 
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